Daniel N. Swisher, Jr

2016 - Sunesis Pharmaceuticals

In 2016, Daniel N. Swisher, Jr earned a total compensation of $1.5M as CEO and President at Sunesis Pharmaceuticals, a 25% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$255,000
Option Awards$772,752
Salary$513,125
Other$3,466
Total$1,544,343

Swisher received $772.8K in option awards, accounting for 50% of the total pay in 2016.

Swisher also received $255K in non-equity incentive plan, $513.1K in salary and $3.5K in other compensation.

Rankings

In 2016, Daniel N. Swisher, Jr's compensation ranked 6,103rd out of 14,075 executives tracked by ExecPay. In other words, Swisher earned more than 56.6% of executives.

ClassificationRankingPercentile
All
6,103
out of 14,075
57th
Division
Manufacturing
2,228
out of 5,486
59th
Major group
Chemicals And Allied Products
731
out of 1,900
62nd
Industry group
Drugs
552
out of 1,543
64th
Industry
Pharmaceutical Preparations
432
out of 1,173
63rd
Source: SEC filing on April 20, 2017.

Swisher's colleagues

We found one more compensation record of an executive who worked with Daniel N. Swisher, Jr at Sunesis Pharmaceuticals in 2016.

2016

Eric Bjerkholt

Sunesis Pharmaceuticals

Chief Financial Officer

News

In-depth

You may also like